الصفحة الرئيسية

كلية العلوم الطبية التطبيقية \ تقنية المختبرات الطبية

جمشيد جاويد سيد أسفا علي

السيرة الذاتية
نسبة اكتمال الملف الشخصي
الجنسية الهندية
التخصص العام تقنية المختبرات الطبية
التخصص الدقيق المختبرات
المسمى الوظيفي أستاذ مشارك
الدرجة العلمية (المرتبة) دكتوراه

نبذه مختصرة

المؤهلات العلمية

PhD Medical Biochemistry

الاهتمامات البحثية

Non-Invasive Molecular diagnostic Markers Molecular mechanisms of drug target & drug resistance Novel Molecular mechanisms

الخبرات والمناصب الإدارية

ASSISTANT PROFESSOR (2015 - Present) CHAIRMAN, Statistics and Information Unit, FAMS, UT (2018- till date) MEMBER & STATISTICAL ANALYST, Quality and Academic Accreditation Committee, FAMS, UT (2017- till date) MEMBER, Continuous Education and E-Learning Committee (2020- till date) MEMBER, Scientific research Committee, Prince Fahd Bin Sultan Research Chair, FAMS, UT (2015- till date)

الجدول الدراسي
الأبحاث والمؤلفات
  • Evaluation of the Association of Omentin 1 rs2274907 A T and rs2274908 G A Gene Polymorphisms with Coronary Artery Disease in Indian Population: A Case-Control Study J Pers Med 2020 Oct 2610(4):194 doi: 103390/jpm10040194PMID: 33114503 (Pubmed Indexed)
  • Molecular Evaluation of MicroRNA-146 Gene Variability (rs2910164 C G) and its Association with Increased Susceptibility to Coronary Artery DiseaseMicrorna 2020 Dec 9 doi: 102174/2211536609666201209151130 Online ahead of printPMID: 33297927 (Pubmed Indexed)
  • The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients Microrna 20209(1):49-57 doi: 102174/2211536608666190225111234PMID: 30799804 (Pubmed Indexed)
  • Incidence of MicroR-4513C/T Gene Variability in Coronary Artery Disease - A Case-Control Study Endocr Metab Immune Disord Drug Targets 201919(8):1216-1223 doi: 102174/1871530319666190417111940PMID: 31038082 (Pubmed Indexed)
  • Potential Impact of MicroRNA-423 Gene Variability in Coronary Artery Disease Endocr Metab Immune Disord Drug Targets 201919(1):67-74 doi: 102174/1871530318666181005095724PMID: 30289085 (Pubmed Indexed)
  • MicroRNA-224 (rs188519172 AG) Gene Variability is Associated with a Decreased Susceptibility to Coronary Artery Disease: A Case-Control Study Microrna 20198(3):198-205 doi: 102174/2211536608666181211153859PMID: 30539710 (Pubmed Indexed)
  • Potential Impact of COMT-rs4680 G A Gene Polymorphism in Coronary Artery Disease J Cardiovasc Dev Dis 2018 Jul 135(3)(Pubmed Indexed)
  • Clinical significance of circulatory miRNA-21 as an efficient noninvasive biomarker for the screening of Lung cancer patients Asian Pac J Cancer Prev 2018 Sep 2619(9):2607-2611(Pubmed Indexed)
  • A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population Asian Pac J Cancer Prev 2018 Mar 2719(3):859-866(Pubmed Indexed)
  • A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients Leuk Lymphoma 2017 Jul58(7):1694-1701 (Pubmed Indexed)
  • Utility of amplification Refractory Mutation System PCR for the detection of JAK2 mutation in Chronic Myeloproliferative Disorders Int J Adv Res2017 5(1): 829-837
  • Optimization of allele specific PCR (AS-PCR) for the early detection of FLT3 (D835Y) mutation in Acute Myeloid Leukemia patients at Tabuk, Saudi Arabia Int J Adv Res Jan 2017 5(1), 817-822
  • Involvement of CASP3 promoter polymorphism (-1337 C  G) in the development and progression of non-small cell lung cancer Tumour Biol 2016 Jul37(7):9255-62 (Pubmed Indexed)
  • Detection of HER2 polymorphism and expression using circulating DNA and RNA as a tool in lung adenocarcinoma patients: a case control study Ann Transl Med 2016 Jun4(11):209 (Pubmed Indexed)
  • Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients South Asian J Cancer 2016 Jan-Mar5(1):33-6(Pubmed Indexed)
  • The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study Asian Pac J Cancer Prev 201617(3):1215-9(Pubmed Indexed)
  • Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients Clin Transl Oncol 2016 Jul18(7):728-34 (Pubmed Indexed)
  • Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients Tumour Biol 2016 Jan37(1):857-63 (Pubmed Indexed)
  • Glutathione S-transferase M1 and T1 (rs4025935 and rs71748309) null genotypes are associated with increased susceptibility to coronary artery disease in Indian populations Acta Cardiol 201671(6):678-684 (Pubmed Indexed)
  • Role of survivin re-expression in the development and progression of non-small cell lung cancerTumour Biol 2015 Jul36(7):5543-50 (Pubmed Indexed)
  • Association of p53 and mdm2 in the development and progression of non-small cell lung cancer Tumour Biol 2015 Jul36(7):5425-32 (Pubmed Indexed)
  • Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients Tumour Biol 2015 Jun 36(6):4253-60(Pubmed Indexed)
  • CC genotype of anti-apoptotic gene BCL-2 (-938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer Clin Transl Oncol 2015 Apr17(4):289-95 (Pubmed Indexed)
  • BAX G(-248)A gene polymorphism and its association with risk of Non-small cell lung cancer- a case control study Open J Apoptosis, 2015 4(2):47-58
  • Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients Indian J Cancer 2015 Jul-Sep 52(3):314-8 (Pubmed Indexed)
  • Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients Asian Pac J Cancer Prev 201516(17):7653-8(Pubmed Indexed)
  • Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study Asian Pac J Cancer Prev 201516 (17):7529-34 (Pubmed Indexed)
  • Cell Free EGFR mRNA Expression and Implications for Survival and Metastasis in Non-Small Cell Lung Cancer Cases Asian Pac J Cancer Prev 201516(15):6445-9 (Pubmed Indexed)
  • Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features Clin Transl Oncol 2015 Oct 17(10):779-87 (Pubmed Indexed)
  • Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients World J Oncol 2015 Apr6(2):321-328 (Pubmed Indexed)
  • RASSF1 & PTEN promoter hypermethylation influences the outcome in epithelial ovarian Cancer Clinical Ovarian and Other Gynecologic Cancer2015 DOI: 101016/ jcogc 2014 12002
  • TP53 is a Mutational Target in Non Small Cell Lung Cancer Patients and its Pro/Pro Variant is Potentially Contributing to Cancer Susceptibility J Carcinogenesis & Mutagenesis 2013 4(1):1-7
  • Biological and Clinical Implications of Functional Promoter Polymorphism of CASPASE 9 Gene in NSCLC Patients J Mol Biomarkers Diagn 2013 S (8):1-7
  • TP53 Gene Polymorphism in Epithelial Ovarian Carcinoma Patients from North Indian Population and its Pro/Pro Variant is Potentially Contributing to Cancer Susceptibility J Genet Syndr Gene Ther 2013 4(5):1-6
  • Epigenetic Silencing of DAPK1 Gene is Associated with Faster Disease Progression in Indian Populations with Chronic Myeloid Leukemia J Cancer Sci Ther 2013 5(4):144-149
  • Inactivation of RIZ1 gene by promoter hypermethylation is associated with disease progression and resistance to Imatinib in Indian Chronic myelogenous leukemia patients, first study from India J Cancer Sci Ther 2013 5(2):045-051
  • Inactivation of P16 (INK4a) Gene by Promoter Hypermethylation is Associated with Disease Progression in Chronic Myelogenous Leukaemia J Carcinogenesis & Mutagenesis 2013 4(2):1-6
  • Biological and Clinical Implications of Exon 8 P53 (R282W) Gene Mutation in Relation to Development and Progression of Chronic Myeloid Leukaemia Patients in Indian Population J Cell Sci Ther 2013 4(1):1-6
  • Clinical and Prognostic Significance of R282W p53 gene mutation in North India Patients with Non Small Cell Lung Carcinoma Translational Medicine 2012 2(2):1-5
  • Impact of MDM2 SNP309TG Polymorphism: Increased risk of developing Non Small Cell Lung Cancer and Poor Prognosis in Indian Patients J Cancer Sci Ther20124(10):341-346
  • Clinical and Prognostic Significance of Promoter Polymorphism (-31GC) of Anti Apoptotic Gene Survivin (BIRC5) in North Indian Patients with Non-Small Cell Lung Cancer J Cancer Sci Ther2012 4(9):276-280
جوائز التميز
  • Best Young Scientist Award by Society of Cancer Research, India (2015)
  • Senior Research Fellow, Department of Non Communicable Disease, Indian Council of Medical Research, New Delhi, India (2010-2014)
  • DBT, BCIL Fellow, Department of Biotechnology: Ministry of Science and Technology New Delhi, India (2008-2009)
المشاريع البحثية
اسم المشروع وصف المشروع
To investigate the role of circulatory miRNAs (c-miRNAs) as potential biomarkers for the early diagnosis of Lung Cancer
To develop PCR based genetic tests for the management of treatment among the patients with cardiovascular disease from Tabuk, Saudi Arabia
Molecular mechanisms responsible for acquired resistance to EGFR-tyrosine kinase inhibitors in Nonsmall cell lung cancer
Prognostic significance of apoptosis gene alterations in Non-small cell lung cancer patients
معلومات التواصل
البريد الإلكتروني : jali@ut.edu.sa